XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents a summary of the revenues and adjusted EBITDA of our three operating segments for the three months ended March 31, 2024 and 2023:
Three Months Ended March 31,
(In thousands)20242023
Revenues by segment:
RCM$53,038 $48,631 
EHR
Recurring revenue
Acute EHR25,910 27,613 
Post-acute EHR582 3,906 
Total recurring EHR revenue26,492 31,519 
Non-recurring revenue
Acute EHR1,449 3,292 
Post-acute EHR81 380 
Total non-recurring EHR revenue1,530 3,672 
Total EHR revenue$28,022 $35,191 
Patient Engagement2,187 2,411 
Total revenues$83,247 $86,233 
Adjusted EBITDA by segment:
RCM$6,396 $7,898 
EHR2,929 6,157 
Patient Engagement129 588 
Total adjusted EBITDA$9,454 $14,643 
Schedule of Reconciliation of Net Income from Continuing Operations to Adjusted Income (Loss) from Before Interest, Taxes, Depreciation and Amortization
The following table reconciles net income to adjusted EBITDA:
Three Months Ended March 31,
(In thousands)20242023
Net income (loss), as reported$(2,516)$3,084 
Depreciation expense400 499 
Amortization of software development costs2,742 1,486 
Amortization of acquisition-related intangibles3,127 4,014 
Stock-based compensation800 1,247 
Severance and other non-recurring charges3,844 1,104 
Interest expense4,072 2,669 
Gain on sale of AHT(1,250)— 
Other(173)(269)
Provision (benefit) for income taxes(1,592)809 
Total adjusted EBITDA$9,454 $14,643